Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22030392 | 0.98 | ALDH1A1 (0.49) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL18711241 | 0.91 | KMT2A (0.48) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL20734660 | 0.91 | KMT2A (0.48) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL259671 | 0.91 | ACE2 (0.47) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL21923029 | 0.91 | ALDH1A1 (0.44) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL9607158 | 0.89 | KMT2A (0.47) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL261011 | 0.89 | ACE2 (0.46) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL20655943 | 0.89 | ACE2 (0.46) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL9607157 | 0.89 | KMT2A (0.47) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL6284635 | 0.88 | KMT2A (0.49) | ALDH1A1KMT2ARAB9AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697735-B2 | Solid oleaginous compositions | TOTAL MARKETING SERVICES (FR) | 2023-07-11 | — | — | US | disclosed |
| US-11697735-B2 | Solid oleaginous compositions | TOTAL MARKETING SERVICES (FR) | 2023-07-11 | — | — | US | disclosed |
| US-11365317-B2 | Solid binders | TOTAL MARKETING SERVICES (FR) | 2022-06-21 | — | — | US | disclosed |
| EP-3612616-B1 | SOLID BITUMEN AT AMBIENT TEMPERATURE | TOTAL MARKETING SERVICES (FR) | 2022-06-01 | — | — | EP | disclosed |
| US-11339116-B2 | Reactive separation process to convert cyclic alkylene ureas into their corresponding alkylene amines | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-05-24 | — | — | US | disclosed |
| US-11332606-B2 | Clear binder that is solid when cold | TOTAL MARKETING SERVICES (FR) | 2022-05-17 | — | — | US | disclosed |
| EP-3510103-B1 | CLEAR SOLID COLD BINDER | TOTAL MARKETING SERVICES (FR) | 2022-02-16 | — | — | EP | disclosed |
| US-11242287-B2 | Bitumen which is solid at ambient temperature | TOTAL MARKETING SERVICES (FR) | 2022-02-08 | — | — | US | disclosed |
| US-11214549-B2 | Process for making higher ethylene amines | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-01-04 | — | — | US | disclosed |
| US-11198105-B2 | Method for manufacturing material in the form of granules that can be used as road binder or sealing binder and device for manufacturing same | TOTAL MARKETING SERVICES (FR) | 2021-12-14 | — | — | US | disclosed |
| US-7750113-B2 | Supramolecular polymers | ARKEMA FRANCE (FR) | 2010-07-06 | — | — | US | disclosed |
| WO-2008107551-A2 | BITUMINOUS COMPOSITION WITH THERMOREVERSIBLE PROPERTIES | TOTAL RAFFINAGE MARKETING (FR) | 2008-09-12 | — | — | WO | disclosed |
| US-20080167442-A1 | SUPRAMOLECULAR POLYMERS | ARKEMA FRANCE (FR) | 2008-07-10 | — | — | US | disclosed |
| US-20080167442-A1 | SUPRAMOLECULAR POLYMERS | ARKEMA FRANCE (FR) | 2008-07-10 | — | — | US | disclosed |
| US-7348397-B2 | Supramolecular polymers | ARKEMA FRANCE (FR) | 2008-03-25 | — | — | US | disclosed |
| US-7348397-B2 | Supramolecular polymers | ARKEMA FRANCE (FR) | 2008-03-25 | — | — | US | disclosed |
| US-7250487-B2 | Supramolecular polymers | ARKEMA FRANCE (FR) | 2007-07-31 | — | — | US | disclosed |
| US-7250487-B2 | Supramolecular polymers | ARKEMA FRANCE (FR) | 2007-07-31 | — | — | US | disclosed |
| US-20070123694-A1 | Supramolecular polymers | TOURNILHAC FRANCOIS-GENES | 2007-05-31 | — | — | US | disclosed |
| US-20070123694-A1 | Supramolecular polymers | TOURNILHAC FRANCOIS-GENES | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11339116-B2 | Reactive separation process to convert cyclic alkylene ureas into their corresponding alkylene amines | UTP20, CGAS, UMPS | ALDH1A1 2104/4885KMT2A 2288/4885RAB9A 3591/4885 |
| US-11214549-B2 | Process for making higher ethylene amines | HRH4, HRH3, HRH1 | ALDH1A1 1957/4885KMT2A 997/4885RAB9A 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.